scholarly journals Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta‐analysis

2019 ◽  
Vol 8 (17) ◽  
pp. 7454-7468 ◽  
Author(s):  
Yuan Feng ◽  
Jia Wang ◽  
Dezhong Tan ◽  
Peng Cheng ◽  
Anhua Wu
Tumor Biology ◽  
2014 ◽  
Vol 35 (6) ◽  
pp. 5589-5592 ◽  
Author(s):  
Yiping Feng ◽  
Miaoyu Zeng ◽  
Qingsheng Xu
Keyword(s):  

2019 ◽  
Author(s):  
Charlie N Saunders ◽  
Alex J Cornish ◽  
Ben Kinnersley ◽  
Philip J Law ◽  
Elizabeth B Claus ◽  
...  

Abstract Background The etiological basis of glioma is poorly understood. We have used genetic markers in a Mendelian Randomisation (MR) framework to examine if lifestyle, cardiometabolic and inflammatory factors influence the risk of glioma. This methodology reduces bias from confounding and is not affected by reverse causation. Methods We identified genetic instruments for 37 potentially modifiable risk factors and evaluated their association with glioma risk using data from a genome-wide association study of 12,488 glioma patients and 18,169 controls. We used the estimated odds ratio of glioma associated with each of the genetically defined traits to infer evidence for a causal relationship with the following exposures: lifestyle and dietary factors (height, plasma IGF-1, blood carnitine, blood methionine, blood selenium, blood zinc, circulating adiponectin, circulating carotenoids, iron status, serum calcium, vitamin [A1, B12, B6, E and 25-hydroxyvitamin D], fatty acids levels [mono-unsaturated, omega-3 and omega-6] and circulating fetuin-A); cardiometabolic factors (birth weight, HDL cholesterol, LDL cholesterol, total cholesterol, total triglycerides, basal metabolic rate, body fat percentage, body mass index, fasting glucose, fasting proinsulin, HbA1C levels, diastolic and systolic blood pressure, waist circumference, waist-to-hip ratio) were included; inflammatory factors (C-reactive protein (CRP), plasma IL-6 sRa and serum IgE). Results After correction for the testing of multiple potential risk factors and excluding associations driven by one single nucleotide polymorphism (SNP) no significant association with glioma risk was observed (i.e. PCorrected > 0.05). Conclusions This study did not provide evidence supporting any of the 37 factors examined as having a significant influence on glioma risk.


2020 ◽  
Vol 48 (8) ◽  
pp. 030006052093969
Author(s):  
Honcho Lei ◽  
Chiho To ◽  
Unpeng Lei

Objectives We investigated the association between the consumption of fresh and processed fish and glioma risk using a meta-analysis approach. Methods We selected and analyzed observational studies that discussed the relationships between fresh and processed fish intake on glioma risk from PubMed, Web of Science, Embase, and the SinoMed and Wanfang databases from inception to 31 March 2020. Studies were selected according to pre-established eligibility criteria and data were extracted separately by two researchers. A meta-analysis was conducted based on a random-effects model to provide pooled odds ratios (OR) and 95% confidence intervals (CIs). Results Eight studies considered the relationship between fish intake (seven fresh and seven processed fish) and glioma risk and were included in this meta-analysis. The OR effect size for fresh fish intake and glioma risk was 0.72 (95%CI 0.53–0.97) and the overall OR effect size for processed fish intake and glioma risk was 1.88 (95%CI 1.06–3.34). Conclusion Dietary intake of fresh fish may reduce the risk of glioma, but consumption of processed fish may increase the risk of glioma. This study had some limitations, and further studies are therefore required to clarify the associations between fish intake and glioma risk.


2019 ◽  
Vol 10 (19) ◽  
pp. 4679-4688
Author(s):  
Weiping Liu ◽  
Hongyu Long ◽  
Mengqi Zhang ◽  
Yanjing Wang ◽  
Qiong Lu ◽  
...  

2019 ◽  
Vol 10 (6) ◽  
pp. 1108-1119 ◽  
Author(s):  
Mehran Rahimlou ◽  
Nasrin Banaie Jahromi ◽  
Nazila Hasanyani ◽  
Amirhossein Ramezani Ahmadi

ABSTRACT There have been various clinical studies on the effect of flaxseed-derived products on circulating inflammatory biomarkers, but the findings from these are contradictory. The aim of the present study was to clarify any association. A comprehensive literature search was conducted from inception to May 2018. From the eligible trials, 32 articles describing studies conducted on adults aged 18–70 y were selected for the meta-analysis. Meta-analyses using the random-effects model were performed to investigate the data and results showed significant effects of flaxseed intake on circulating high-sensitivity CRP (hs-CRP) [weighted mean difference (WMD) = −0.75; 95% CI: −1.19, −0.30; P < 0.001] and TNFα (WMD = −0.38; 95% CI: −0.75,–0.01; P = 0.04). However, no significant changes were found in IL6 concentration (WMD = −0.24; 95% CI: –0.70, 0.21; P = 0.28) and C-reactive protein (CRP) (WMD = −0.34; 95% CI:–0.89, 0.20; P = 0.22). Moreover, by eliminating 1 of the studies from the sensitivity analysis, changes in IL6 concentration were significant (WMD = −0.44; 95% CI: –0.81, –0.08). The changes in inflammatory biomarkers were dependent on study design (parallel or crossover), supplement type (flaxseed, flaxseed oil, or lignan), study quality (high or low), and participants’ age and BMI. According to this meta-analysis, flaxseed significantly reduced circulating concentrations of hs-CRP and TNFα, but did not affect IL6 and CRP. Further research is needed to examine the effect of different doses and long-term benefits of flaxseed and its derivatives on inflammatory factors.


2016 ◽  
Vol 54 (2) ◽  
pp. 1314-1325 ◽  
Author(s):  
Ling Qi ◽  
Hong-quan Yu ◽  
Yu Zhang ◽  
Li-juan Ding ◽  
Dong-hai Zhao ◽  
...  

2017 ◽  
Vol 137 (2) ◽  
pp. 357-365 ◽  
Author(s):  
Yu-Long Lan ◽  
Xun Wang ◽  
Jia-Cheng Lou ◽  
Bin-Bin Ma ◽  
Jin-Shan Xing ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document